Histone Deacetylases and reversible acetylation in signaling and disease
Histone Deacetylases and reversible acetylation in signaling and disease
批准号:
7750268
负责人:
JOHN M DENU
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2010-06-30
关键词:
AcetylationAgingAlzheimer&aposs DiseaseBiologicalBiological ProcessBiologyCell physiologyChromatinCloningDeacetylaseDevelopmentDiabetes MellitusDiseaseEnzymesExplosionFundingGene ExpressionGene Expression RegulationHistone AcetylationHistonesLearningLinkLysineMalignant NeoplasmsMemory LossMetabolicMetabolic PathwayMetabolismModificationMolecularNeurodegenerative DisordersParkinson DiseasePathway interactionsPhosphorylationPlayProtein AcetylationProteinsRegulationRequest for ProposalsResearchRoleScientistSignal TransductionSirtuinsStagingStructureTrainingWorkage relatedcareercell growth regulationenzyme mechanismhistone acetyltransferaseprotein functionpublic health relevancesymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Regulation of protein function by covalent modifications, such as phosphorylation, is fundamental to many biological processes. Over the last several years, emerging evidence suggests that acetylation of protein lysine residues may rival reversible phosphorylation as a major regulatory mechanism of cellular pathways. Histone acetylation is a classical example of how reversible acetylation controls the structure and function of chromatin, permitting the appropriate level of gene expression. However, it is now established that >100 non-histone proteins might be acutely regulated by this modification. With the first cloning (~10 years ago) of histone acetyltransferase (HATs) and deacetylase (HDACs) enzymes, there has been an explosion of research in the field. This FASEB conference will focus primarily on the biology and mechanism of the HDACs. There will be particular emphasis on the function of these enzymes in pathways that are associated with age-related diseases, such as neurodegenerative disorders, Alzheimer's and Parkinson's disease, memory loss, diabetes and cancer. In addition to providing a molecular understanding of the roles played by HDACs in gene regulation, there will be an important emphasis on acetylation of non-histone proteins and the impact to central metabolic pathways. Particularly, key topics will include the sirtuins deacetylases, which are NAD-dependent deacetylases involved in aging and metabolism. This conference proposal requests support for attendance and participation by 12 scientists who are currently at the early stages of their careers. Use of funds for this purpose will provide an excellent training opportunity for early-career scientists who will present their work and learn about the latest developments in this burgeoning field. Regulation of cellular proteins by covalent modifications is fundamental to many biological processes. Over the last several years, emerging evidence suggests that acetylation of proteins controls the ability to perform their cellular functions. This 2009 FASEB summer conference "Histone deacetylases and reversible acetylation in signaling and disease" will focus primarily on the biological pathways and mechanisms of the enzymes that remove this modification, namely the histone deacetylases, or HDACs. There will be particular emphasis on the function of these enzymes in pathways that are associated with age-related diseases, such as neurodegenerative disorders, Alzheimer's and Parkinson's disease, memory loss, diabetes and cancer. In addition to providing a molecular understanding of the roles played by HDACs in gene regulation, there will be an important emphasis on how the enzymes impact central metabolic pathways. Particularly, key topics will include the sirtuins deacetylases, which are metabolically-link deacetylases involved in aging and metabolic regulation. This conference proposal requests support for attendance and participation by 12 scientists who are currently at the early stages of their careers. Use of funds for this purpose will provide an excellent training opportunity for early-career scientists who will present their work and learn about the latest developments in this burgeoning field.
PUBLIC HEALTH RELEVANCE: Project Narrative Regulation of cellular proteins by covalent modifications is fundamental to many biological processes. Over the last several years, emerging evidence suggests that acetylation of proteins controls the ability to perform their cellular functions. This 2009 FASEB summer conference "Histone deacetylases and reversible acetylation in signaling and disease" will focus primarily on the biological pathways and mechanisms of the enzymes that remove this modification, namely the histone deacetylases, or HDACs. There will be particular emphasis on the function of these enzymes in pathways that are associated with age-related diseases, such as neurodegenerative disorders, Alzheimer's and Parkinson's disease, memory loss, diabetes and cancer. In addition to providing a molecular understanding of the roles played by HDACs in gene regulation, there will be an important emphasis on how the enzymes impact central metabolic pathways. Particularly, key topics will include the sirtuins deacetylases, which are metabolically-link deacetylases involved in aging and metabolic regulation. This conference proposal requests support for attendance and participation by 12 scientists who are currently at the early stages of their careers. Use of funds for this purpose will provide an excellent training opportunity for early-career scientists who will present their work and learn about the latest developments in this burgeoning field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamics and molecular mechanisms linking metabolism and the epigenome
-
批准号:10624003
-
项目类别:
-
资助金额:$66.93万
-
财政年份:2023
-
负责人:JOHN M DENU
-
依托单位:
Dietary regulation of the hepatic epigenome
-
批准号:10211950
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2021
-
负责人:JOHN M DENU
-
依托单位:
Dietary regulation of the hepatic epigenome
-
批准号:10434846
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2021
-
负责人:JOHN M DENU
-
依托单位:
Dietary regulation of the hepatic epigenome
-
批准号:10640272
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2021
-
负责人:JOHN M DENU
-
依托单位:
Linking mitochondrial variation and lifespan amongst five species of Rodentia
-
批准号:9077372
-
项目类别:
-
资助金额:$7.65万
-
财政年份:2016
-
负责人:JOHN M DENU
-
依托单位:
Role of Sirt3 in Aging and Caloric Restriction
-
批准号:8706746
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2011
-
负责人:JOHN M DENU
-
依托单位:
Role of Sirt3 in Aging and Caloric Restriction
-
批准号:8313913
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2011
-
负责人:JOHN M DENU
-
依托单位:
Role of Sirt3 in Aging and Caloric Restriction
-
批准号:8512636
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2011
-
负责人:JOHN M DENU
-
依托单位:
Role of Sirt3 in Aging and Caloric Restriction
-
批准号:8025259
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2011
-
负责人:JOHN M DENU
-
依托单位:
Reversible Protein Acetylation and Chromatin Function
-
批准号:8005210
-
项目类别:
-
资助金额:$12.32万
-
财政年份:2010
-
负责人:JOHN M DENU
-
依托单位:
SIRTUIN PROTEIN-HISTON DEACETYLASE STUDY
-
批准号:7954658
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:JOHN M DENU
-
依托单位:
NAD Metabolism and Signaling Conference
-
批准号:7673197
-
项目类别:
-
资助金额:$1.15万
-
财政年份:2009
-
负责人:JOHN M DENU
-
依托单位:
Reversible protein acetylation and sirtuin function
-
批准号:8258741
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible protein acetylation and sirtuin function
-
批准号:8453444
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible Protein Acetylation and Chromatin Function
-
批准号:7614396
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible Protein Acetylation and Chromatin Function
-
批准号:7048574
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible Protein Acetylation and Chromatin Function
-
批准号:6572590
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible protein acetylation and sirtuin function
-
批准号:8108445
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible Protein Acetylation and Chromatin Function
-
批准号:6736900
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
Reversible protein acetylation and sirtuin function
-
批准号:10435525
-
项目类别:
-
资助金额:$44.97万
-
财政年份:2003
-
负责人:JOHN M DENU
-
依托单位:
海外基金